Skip to main content
. 2013 Oct 21;13:487. doi: 10.1186/1471-2407-13-487

Figure 2.

Figure 2

Overall survival (OAS) and disease-free survival (DFS) for TNBC (n = 844) versus non-TNBC (n = 8.312) and for TNBC versus the groups defined by HR status and Her2 status (adjusted for year of diagnosis, tumor size, grading, nodal status, menopausal status, and comorbidity).